NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Deck Bio

Deck Bio

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://deck.bio/

Last Round

Seed

Apr 9, 2026

Total Funding Raised

$3.1M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Deck Bio is a biotechnology company developing T cell engagers that recognize multiple cancer signals to treat solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

multi-target immunotherapyT cell engagerssolid tumor therapyimmuno-oncologypreclinical biotechdrug discovery platformTCR discoveryTCR engineeringbiologicspMHC targetingsoluble protein therapyoff-the-shelf immunotherapyantigen escapetumor heterogeneitycomputational drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Deck Bio Comps

Public and private peers based on sector, stage, and business model.

Deck Bio comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Deck Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 9, 2026

Deck Bio Investors

Notable investors and investment history

Deck Bio investors
InvestorRounds
BrightEdgeSeed
Mission BioCapitalSeed
Impact VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 9, 2026

    $3.1M round with Mission BioCapital and BrightEdge

Deck Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Deck Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Deck Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Year Founded2023
Last FundingApr 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.